China’s Xi Vows To Boost Iran Trade And Help Revive Nuclear Deal

-Financial Times

byBenzinga Newsdesk

February 14, 2023

1 minute read

-Financial Times

Raymond James Believes Favorable Pricing Has Made Travelers Companies Stock Attractive To Investors

By Shivani Kumaresan

Today, 4:50 AM

Raymond James analyst C. Gregory Peters upgraded Travelers Companies Inc (NYSE:TRV) to Strong Buy from Market Perform with a price target of $185,…

TRV

Cassava Sciences Stock Looks Ready To Break Out If This Pattern Is Confirmed

By Tyler Bundy

Today, 4:50 AM

Cassava Sciences Inc. (NASDAQ: SAVA) shares were moving Monday after the company announced positive clinical data with SavaDx.

SAVA

Mizuho Comments On UniQure’s Upcoming Low-Dose Huntington’s Gene Therapy Trial Data

By Vandana Singh

Today, 4:50 AM

The much-awaited one-year data for the entire low-dose cohort for UniQure NV's (NASDAQ: QURE) AMT-130 gene therapy in Huntington's disease is expected at any time.

QURE

Omeros Submits Response To FDA Regarding Narsoplimab Application In HSCT-TMA

By Vandana Singh

Today, 4:50 AM

Omeros Corporation (NASDAQ: OMER) has submitted to the FDA its response to Complete Response Letter for narsoplimab in hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).

OMER

China’s Xi Vows To Boost Iran Trade And Help Revive Nuclear Deal

Related Posts

Raymond James Believes Favorable Pricing Has Made Travelers Companies Stock Attractive To Investors

Cassava Sciences Stock Looks Ready To Break Out If This Pattern Is Confirmed

Mizuho Comments On UniQure’s Upcoming Low-Dose Huntington’s Gene Therapy Trial Data

Omeros Submits Response To FDA Regarding Narsoplimab Application In HSCT-TMA